Try out PMC Labs and tell us what you think. Learn More.

Logo of cardiologyJournal's HomeManuscript SubmissionAims and ScopeAuthor GuidelinesEditorial BoardHome
ISRN Cardiol. 2013; 2013: 907848.
Published online 2013 Dec 14. doi: 10.1155/2013/907848
PMCID: PMC3880712
PMID: 24455302

Retracted: Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?

This article entitled “Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?” [1], published in ISRN Cardiology, has been retracted upon the authors' request, as it was found to include erroneous data that their findings and conclusions cannot be relied upon. Additionally, the article was submitted for publication by the author Gemina Doolub without the knowledge and approval of the other author Erica Dall'Armellina.

References

1. Doolub G, Dall'Armellina E. Intracoronary adenosine versus intravenous adenosine during primary PCI for ST-elevation myocardial infarction: which one offers better outcomes in terms of microvascular obstruction? ISRN Cardiology. 2013;2013:8 pages.248476 [PMC free article] [PubMed] [Google Scholar] Retracted

Articles from ISRN Cardiology are provided here courtesy of Hindawi Limited